Cencora, Inc. $COR Stake Raised by Jefferies Financial Group Inc.

Jefferies Financial Group Inc. lifted its stake in shares of Cencora, Inc. (NYSE:COR) by 195.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 119,653 shares of the company’s stock after acquiring an additional 79,102 shares during the quarter. Jefferies Financial Group Inc. owned about 0.06% of Cencora worth $40,413,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in the stock. Oakworth Capital Inc. acquired a new position in Cencora in the fourth quarter worth approximately $26,000. Elyxium Wealth LLC acquired a new position in Cencora in the fourth quarter worth approximately $27,000. Archer Investment Corp grew its position in Cencora by 134.3% in the fourth quarter. Archer Investment Corp now owns 82 shares of the company’s stock worth $28,000 after buying an additional 47 shares during the last quarter. IAG Wealth Partners LLC acquired a new position in Cencora in the third quarter worth approximately $30,000. Finally, Cloud Capital Management LLC acquired a new position in Cencora in the third quarter worth approximately $31,000. Institutional investors and hedge funds own 97.52% of the company’s stock.

Cencora Trading Up 3.6%

Shares of NYSE:COR opened at $275.01 on Friday. The firm has a fifty day moving average of $305.70 and a two-hundred day moving average of $336.77. The firm has a market capitalization of $53.51 billion, a P/E ratio of 21.09, a price-to-earnings-growth ratio of 1.27 and a beta of 0.64. Cencora, Inc. has a 12-month low of $244.82 and a 12-month high of $377.54. The company has a quick ratio of 0.59, a current ratio of 0.95 and a debt-to-equity ratio of 3.40.

Cencora (NYSE:COR) last released its quarterly earnings data on Wednesday, May 6th. The company reported $4.75 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.82 by ($0.07). Cencora had a net margin of 0.78% and a return on equity of 135.20%. The business had revenue of $78.36 billion during the quarter, compared to analyst estimates of $81.09 billion. During the same period in the previous year, the firm posted $4.42 EPS. The firm’s revenue for the quarter was up 3.9% on a year-over-year basis. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. On average, equities analysts expect that Cencora, Inc. will post 17.79 EPS for the current fiscal year.

Cencora declared that its board has authorized a share buyback program on Thursday, May 21st that permits the company to buyback $2.00 billion in shares. This buyback authorization permits the company to buy up to 3.9% of its shares through open market purchases. Shares buyback programs are generally an indication that the company’s board of directors believes its shares are undervalued.

Cencora Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, June 1st. Shareholders of record on Friday, May 15th will be given a dividend of $0.60 per share. The ex-dividend date of this dividend is Friday, May 15th. This represents a $2.40 dividend on an annualized basis and a yield of 0.9%. Cencora’s payout ratio is currently 18.40%.

Wall Street Analysts Forecast Growth

COR has been the topic of several recent research reports. William Blair initiated coverage on shares of Cencora in a research report on Tuesday, April 28th. They issued a “market perform” rating on the stock. Barclays lifted their price target on shares of Cencora from $400.00 to $425.00 and gave the stock an “overweight” rating in a research report on Friday, February 13th. Weiss Ratings cut shares of Cencora from a “buy (b)” rating to a “buy (b-)” rating in a research report on Friday. Evercore set a $360.00 price objective on shares of Cencora in a research report on Wednesday, April 8th. Finally, Robert W. Baird lowered their price objective on shares of Cencora from $420.00 to $339.00 and set an “outperform” rating on the stock in a research report on Thursday, May 7th. Twelve analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $380.25.

Cencora Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.